| Ticker | Company | Mkt Cap▼ | Price | Chg% | Volume |
|---|---|---|---|---|---|
| Medtronic plc | $110.1b | $83.44 | -0.4% | 6.6M | |
| Edwards Lifesciences Corp | $45.8b | $84.15 | +5.6% | 11.8M | |
| Alcon Inc. Ordinary Shares | $35.9b | $75.90 | +0.1% | 752.3K | |
| Biogen Inc. Common Stock | $27.5b | $184.39 | -1.9% | 723.4K | |
| Zimmer Biomet Holdings, Inc. | $17.3b | $91.26 | -1.3% | 2.8M | |
| Glaukos Corporation | $6.1b | $121.48 | +0.5% | 455.0K | |
| Bausch + Lomb Corporation | $5.4b | $15.82 | +0.3% | 256.3K | |
| Denali Therapeutics Inc. Common Stock | $2.9b | $19.89 | +2.3% | 1.2M | |
| BioAge Labs, Inc. Common Stock | $0.7b | $17.00 | -1.4% | 384.4K | |
| Bioventus Inc. Class A Common Stock | $0.6b | $10.09 | +3.9% | 384.2K | |
| Anteris Technologies Global Corp. Common Stock | $496.9m | $5.57 | +0.7% | 663.5K | |
| AC Immune SA | $260.5m | $2.85 | -4.0% | 144.6K | |
| LENZ Therapeutics, Inc. Common Stock | $259.9m | $9.38 | +2.5% | 656.1K | |
| Alector, Inc. Common Stock | $222.9m | $2.40 | -1.0% | 320.6K | |
| Acumen Pharmaceuticals, Inc. Common Stock | $158.1m | $2.57 | -3.8% | 495.6K | |
| Alpha Cognition Inc. Common Stock | $115.7m | $6.99 | +2.0% | 19.8K | |
| Annovis Bio, Inc. | $57.0m | $1.75 | -3.3% | 872.1K | |
| Cognition Therapeutics, Inc. Common Stock | $53.1m | $1.28 | +2.0% | 694.2K | |
| Envoy Medical, Inc. Class A Common Stock | $49.4m | $0.68 | -2.2% | 65.0K | |
| Telomir Pharmaceuticals, Inc. Common Stock | $39.2m | $1.41 | +2.2% | 59.2K | |
| Greenland Mines Ltd. Common Stock | $33.7m | $0.48 | +7.7% | 3.3M | |
| CervoMed Inc. Common Stock | $33.5m | $3.86 | +0.3% | 31.4K | |
| Longeveron Inc. Common Stock | $27.2m | $0.95 | -3.1% | 171.3K | |
| NeuroSense Therapeutics Ltd. Ordinary Shares | $24.4m | $0.77 | +7.7% | 207.7K | |
| Outlook Therapeutics, Inc. Common Stock | $21.0m | $0.32 | +10.9% | 4.1M | |
| 20/20 Biolabs, Inc. Common Stock | $18.4m | $1.63 | +0.6% | 52.4K | |
| OSR Holdings, Inc. Common Stock | $13.6m | $0.69 | +15.9% | 2.0M | |
| FibroBiologics, Inc. Common Stock | $8.0m | $1.43 | -5.3% | 117.8K | |
| Alzamend Neuro, Inc. Common Stock | $4.0m | $1.09 | -3.5% | 51.9K | |
| HCW Biologics Inc. Common Stock | $1.3m | $0.37 | -10.7% | 452.3K |